ALX Oncology
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
ALX Oncology Holdings, Inc. is Lower Risk. The company does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company elevates merit, excellence, and integrity ahead of race and identity-based policies. ALX Oncology does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportHas canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
ALX Oncology has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
ALX Oncology does not publish charitable giving guidelines (1).
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
ALX Oncology protects its employees against viewpoint discrimination (1).
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
ALX Oncology supports DEI within its business practices. From its 2024 Annual Report: “Developing a diverse, equitable and inclusive culture is essential to our success and we are committed to building a workplace where all individuals feel welcomed and valued” (1). The company supports ESG within its business practices. From its DEF 14A: “Our management team and board of directors are working together to oversee the company’s efforts to prioritize and integrate ESG considerations into the company’s business practices and corporate culture” (2).
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
ALX Oncology has not used corporate funds to advance ideological causes, organizations, or policies (1).
Board Bias
Expand Summary
1792 Exchange has not yet compiled data about the board of directors or political contributions of leadership for this company.